Global X S&P Biotech ETF (ASX:CURE)

ASX:CURE Holdings Information

ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Cash stock at 2.00%, TG Therapeutics at 1.69%, Travere Therapeutics at 1.60%, Revolution Medicines at 1.58%, and Alkermes at 1.40%.

• Total Holdings: 10
• Top 10 Percentage: 15.05%
• Asset Class: Equity
• ETF Category: Health Care
• Assets: 41.47M
• PE Ratio: n/a

Top 25 Holdings

As of May 8, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	n/a	Cash	2.00%	n/a
2	TGTX	TG Therapeutics, Inc.	1.69%	11,669
3	TVTX	Travere Therapeutics, Inc.	1.60%	11,062
4	RVMD	Revolution Medicines, Inc.	1.58%	3,287
5	ALKS	Alkermes plc	1.40%	11,787
6	ARWR	Arrowhead Pharmaceuticals, Inc.	1.39%	5,634
7	BEAM	Beam Therapeutics Inc.	1.37%	12,551
8	TWST	Twist Bioscience Corporation	1.35%	6,985
9	CYTK	Cytokinetics, Incorporated	1.34%	5,144
10	KRYS	Krystal Biotech, Inc.	1.33%	1,284